Lucid Diagnostics Inc.
LUCD
$1.26
-$0.03-2.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.17M | 4.35M | 4.19M | 3.80M | 2.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.17M | 4.35M | 4.19M | 3.80M | 2.98M |
| Cost of Revenue | 6.99M | 7.10M | 6.41M | 6.36M | 6.30M |
| Gross Profit | -2.82M | -2.75M | -2.22M | -2.56M | -3.31M |
| SG&A Expenses | 38.37M | 36.41M | 35.24M | 33.99M | 32.77M |
| Depreciation & Amortization | 418.00K | 587.00K | 994.00K | 1.39M | 1.79M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.82M | 50.30M | 49.32M | 48.37M | 47.94M |
| Operating Income | -47.65M | -45.95M | -45.13M | -44.57M | -44.96M |
| Income Before Tax | -61.83M | -45.53M | -44.82M | -46.65M | -47.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.83 | -45.53 | -44.82 | -46.65 | -47.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.83M | -45.53M | -44.82M | -46.65M | -47.03M |
| EBIT | -47.65M | -45.95M | -45.13M | -44.57M | -44.96M |
| EBITDA | -46.76M | -44.79M | -43.56M | -42.58M | -42.57M |
| EPS Basic | -1.20 | -1.07 | -1.13 | -1.23 | -1.27 |
| Normalized Basic EPS | -0.48 | -0.52 | -0.60 | -0.62 | -0.65 |
| EPS Diluted | -1.20 | -1.07 | -1.13 | -1.23 | -1.27 |
| Normalized Diluted EPS | -0.48 | -0.52 | -0.60 | -0.62 | -0.65 |
| Average Basic Shares Outstanding | 225.76M | 201.98M | 185.93M | 177.42M | 171.04M |
| Average Diluted Shares Outstanding | 225.76M | 201.98M | 185.93M | 177.42M | 171.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |